Chimeric 2 microglobulin/CD3 polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8 + T cells

By Margalit Alon  

International Immunology, Vol. 15, Iss. 11, 2003-11 ,pp. : 1379-1387

Oxford University Press

Access to resources Recommend Favorite

Exocytosis of a complement component C3-like protein by tunicate hemocytes

By Raftos D.A.   Fabbro M.   Nair S.V.  

Developmental and Comparative Immunology, Vol. 28, Iss. 3, 2004-03 ,pp. : 181-190

Elsevier

Access to resources Recommend Favorite

Targeting ganglioside epitope 3G11 on the surface of CD4 > T cells suppresses EAE by altering the Treg T h 17 cell balance

By Zhao Zhao   Ciric Bogoljub   Yu Shuo   Zhang Guang-Xian   Rostami Abdolmohamad  

International Immunology, Vol. 22, Iss. 10, 2010-10 ,pp. : 817-826

Oxford University Press

Access to resources Recommend Favorite

A Cell-Based Artificial Antigen-Presenting Cell Coated with Anti-CD3 and CD28 Antibodies Enables Rapid Expansion and Long-Term Growth of CD4 T Lymphocytes

By Thomas A.K.   Maus M.V.   Shalaby W.S.   June C.H.   Riley J.L.  

Clinical Immunology, Vol. 105, Iss. 3, 2002-12 ,pp. : 259-272

Academic Press

Access to resources Recommend Favorite

The effect of anti-CD3-immunotoxin on T lymphocyte function in vitro

By Meng G.   Jiang Y.   Hubbard W.   Thomas J.M.  

Transplant Immunology, Vol. 6, Iss. 1, 1998-03 ,pp. : 53-59

Elsevier

Access to resources Recommend Favorite